FDA Approves New Dosage Form for Cloxacillin Benzathine Animal Drug

Summary

The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplementary new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc., which includes minor revisions to labeling for the antibiotic cloxacillin benzathine.